SUN-LB280: Double Blind Multicenter Phase III Gortec Trial...

Clinical Nutrition 2016 / 09 Vol. 35

SUN-LB280: Double Blind Multicenter Phase III Gortec Trial Evaluating the Efficacy of Oral Immune Modulating Formulae Therapy During Adjuvant Chemoradiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC)

Senesse, P.F., Graff-Cailleaud, P., Sire, C., Gallocher, O., Lavau-Denes, S., Garcia-Ramirez, M., Alfonsi, M., Cupissol, D., Kaminsky, M.-C., Fiore, S., Flori, N., de Forges, H., Garrel, R., Janiszews
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
35
Language:
english
Journal:
Clinical Nutrition
DOI:
10.1016/s0261-5614(16)30636-7
Date:
September, 2016
File:
PDF, 71 KB
english, 2016
Conversion to is in progress
Conversion to is failed